₩ 95400
Key Takeaways
Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA,...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of 237690.KQ is 120496 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
